Black Diamond Therapeutics
Price & Volume
Stats
See more52W Range | $1.91-$7.66 |
Market Cap | $122.2M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.33 |
News
See moreYahoo Finance • 4 days ago
NAYA Biosciences Announces Nomination of New Board Members
Yahoo Finance • last year
With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backing
Yahoo Finance • last year
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • last year
Black Diamond Therapeutics Inc (BDTX) Reports Q3 2023 Financial Results and Corporate Update
About
CEO | Dr. Mark A. Velleca M.D., Ph.D. |
Address | One Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 54 |
